Document Detail


Atypical hemolytic uremic syndrome: telling the difference between H and Y.
MedLine Citation:
PMID:  20877372     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Mutations in the complement factor H (CFH) gene are frequently associated with atypical hemolytic uremic syndrome (aHUS). Hakobyan et al. have developed novel reagents that can rapidly determine the contribution of each CFH allele to the total plasma CFH pool, showing that low-expression CFH alleles are important risk factors for the development of aHUS. These reagents represent a significant contribution to the techniques used to determine susceptibility factors among individuals with aHUS.
Authors:
E Goicoechea de Jorge; Matthew C Pickering
Publication Detail:
Type:  Comment; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Kidney international     Volume:  78     ISSN:  1523-1755     ISO Abbreviation:  Kidney Int.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  721-3     Citation Subset:  IM    
Affiliation:
Centre for Complement and Inflammation Research, Division of Immunology and Inflammation, Faculty of Medicine, Imperial College, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
WT082291MA//Wellcome Trust
Comments/Corrections
Comment On:
Kidney Int. 2010 Oct;78(8):782-8   [PMID:  20703214 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The impact of urinary tract infections in renal transplant recipients.
Next Document:  Ionizing radiation exposure: another underrecognized risk factor for poor health outcomes in dialysi...